Document is current
Any future updates will be listed below
-
Authors
Pucino, Valentina https://orcid.org/0000-0002-7683-4568
Nayar, Saba https://orcid.org/0000-0002-4350-110X
Fehmi, Janev
Baldini, Chiara
Bowman, Simon J.
Fisher, Benjamin A. https://orcid.org/0000-0003-4631-549X
- License Information
-
More Information
Article History
Received: 15 December 2025
Accepted: 18 May 2026
First Online: 19 June 2026
Competing interests
: V.P., J.F. and S.N. declare no competing interests. C.B. has taken consultancy for Novartis, Janssen, BMS, Sanofi, Amgen, Aurina, GSK. B.A.F. has undertaken consultancy for Novartis, BMS, Servier, Galapagos, Roche, UCB, Sanofi, Janssen, AstraZeneca, Otsuka, Amgen, Kiniksa, Cullinan, Quell, OneFour Bio, Spero and Catalys Pacific and received research funding from Janssen, Servier, Galapagos, Celgene, Novartis and Cullinan. S.J.B. has taken consultancy for Abbvie, Aera, Amgen, Argenx, Aurinia, Bain, BMS, EcoR1, Galapagos, Iqvia, J&J, Kiniksa, Novartis, Scitaris.
